Endo pharmaceuticals stock price performance year-to-date

15 Sep 2015 Year-to-date returns are based on September 15, 2015 prices as of 10:07am. TheStreet Ratings team rates ENDO INTERNATIONAL PLC as a Hold with or negative performance for this stock relative to most other stocks. ENDP stock rating and analysis - Endo International PLC : a summary of key 5D 3M YTD 1Y 5Y 10Y All 1Y (-%) Price-to-Operating-Cash-Flow, 7.13. Earnings are forecast to grow 51.86% per year Stable Share Price: ENDP's share price has been volatile over the past 3 months. Market Performance ENDP, NasdaqGS (Nasdaq Global Select), Yes, Common Stock, US, USD, Jul 2000.

Stock In The News Limelight:: Endo International plc ... Mar 03, 2020 · On Monday, March 02, 2020, the Company, Endo International plc, ENDP stock construct a change of 3.44 percent (↑ / Gain) in a total of its share price and having its trading value $5.71, which belongs to Healthcare sector and Drug Manufacturers – Other industry. The company’s Market capitalization was $1.32B with the total Outstanding […] Endo Could Be the Next Activist Target in Generics - RealMoney May 28, 2016 · With about $8.3 billion in net debt and depleting stock price, a sizable acquisition would appear to be tough; however, Endo could look to do a merger-of-equals type of transaction with a Best Healthcare Stocks for Investing Year-to-Date (YTD ...

Avadel Pharmaceuticals Plc: Stock Performance Benchmark ...

1 Year Total % Return. -55.82 Expected Reporting Date. May 8 Brett Girard of Liberty International gives his outlook for shares of Endo International. 1:10  ENDP | Endo International PLC Stock Price & News - WSJ View the latest Endo International PLC (ENDP) stock price, news, historical charts, analyst ratings and financial information from WSJ. Endo International - ENDP - Stock Price & News | The ...

View live ENDO INTERNATIONAL PLC chart to track its stock's price action. involved in the US lawsuits against opioid makers this year and has exposure to.

America’s Most and Least Successful Companies in 2016. Some analysts attribute the weak year-to-date stock performance to the company’s transition from relying heavily on click-based Endo Pharmaceuticals Reports Third Quarter and Nine-Month ... Endo Pharmaceuticals Reports Third Quarter and Nine-Month 2000 Financial Results November 13, 2000 was determined using an average closing price of the Algos common stock for a reasonable period of time before and after the April 17, 2000 measurement date of $13.54 and the 17,832,106 common product performance or other

Endo Pharmaceuticals: The Most Attractive Valeant-Like ...

Endo Pharmaceuticals Reports Third Quarter and Nine-Month 2000 Financial Results November 13, 2000 was determined using an average closing price of the Algos common stock for a reasonable period of time before and after the April 17, 2000 measurement date of $13.54 and the 17,832,106 common product performance or other Avadel Pharmaceuticals Plc: Stock Performance Benchmark ... The Stock Price change percentage is a relevant indicator for computing stock performance. The price change percentage of Avadel Pharmaceuticals Plc over the last month is 11.73%. The Stock Performance of Avadel Pharmaceuticals Plc is significantly higher than the stock performance of its index. Jazz Pharmaceuticals Year to Date Total Returns (Daily) | JAZZ In depth view into Jazz Pharmaceuticals Year to Date Total Returns (Daily) including historical data from 2007, charts, stats and industry comps. Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Wells Fargo Lifts Price Target on Jazz Pharmaceuticals to $189 From $186 Analysts Showing Optimistic Trends For Endo International ...

Hot Stocks To Watch: Wake-Up Call For Titan ...

Will Endo's Troubles Continue to Dent Performance in 2017 ... Will Endo's Troubles Continue to Dent Performance in 2017? Endo is a Zacks Rank #5 (Strong Sell) stock. Its share price increased 33.8% year to date. Strong Upward Pre-Market Activity For Endo International ... May 17, 2016 · The average volume for Endo International has been 9.0 million shares per day over the past 30 days. Endo International has a market cap of $3.0 billion and is … Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue ...

Apr 12, 2016 · At 7.1x 2017 EBITDA of $2.2B, 3.9x 2017 EPS of $6.75, and a 69% discount to our 2017 PMV of $85 per share, we believe that Endo is the most attractive play among the … How Did Mid-Cap Biotech Stocks Fare Last Week? - Market ... Mar 21, 2016 · Year-to-date, the stock has fallen 51.3%. Endo International has a book value of $26.87. With its current price, the stock is trading at a PBV (price … Year-to-Date Portfolio Commentary anticipate greater monthly performance volatility going forward but would also anticipate enhanced return prospects over the long-term if our stock picking proves prescient. The performance summary remains mostly unchanged with our longs broadly underperforming year-to-date while our shorting activities have proved profitable.